The outlook of companies tied to the drug's past presents a challenging investment landscape. While the initial surge generated substantial profits , generic competition have significantly impacted revenue. Investing in associated pharmaceutical companies now requires a discerning assessment of patent protection , evolving patient changes, and t… Read More